Emergence of Fluoroquinolone-Resistant Strains of Vibrio cholerae O1 Biotype El Tor among Hospitalized Patients with Cholera in Calcutta, India
- 1 May 2001
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (5) , 1605-1606
- https://doi.org/10.1128/aac.45.5.1605-1606.2001
Abstract
Ciprofloxacin and norfloxacin are broad-spectrum fluoroquinolones and possess excellent activity against Vibrio cholerae O1 and O139 serogroups ([6][1]). Clinical studies have shown that these drugs are effective in treatment of cholera in adults and children ([2-4][2]). For the past 11 years, weKeywords
This publication has 7 references indexed in Scilit:
- Emergence of Fluoroquinolone Resistance in Strains of Vibrio cholerae Isolated from Hospitalized Patients with Acute Diarrhea in Calcutta, India Antimicrobial Agents and Chemotherapy, 1998
- Efficacy of norfloxacin and doxycycline for treatment of Vibrio cholerae O139 infectionJournal of Antimicrobial Chemotherapy, 1996
- Ciprofloxacin for the Treatment of Cholera: A Randomized, Double-Blind, Controlled Clinical Trial of a Single Daily Dose in Peruvian AdultsClinical Infectious Diseases, 1995
- Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1995
- Double-blind, randomized, controlled clinical trial of norfloxacin for choleraAntimicrobial Agents and Chemotherapy, 1990
- Antibiotic susceptibility testing by a standardized single disk method.1966
- Antibiotic Susceptibility Testing by a Standardized Single Disk MethodAmerican Journal of Clinical Pathology, 1966